Indefinite Delivery Contract 75D30126D21005
Award Date 6/1/26
Last Date to Order 5/31/27
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Pfizer Inc. on June 1, 2026, with a ceiling value of $505,272,000 for FDA-approved COVID-19 vaccines for adults aged 19 and older under Executive Order 14398. No set-aside applies. The contract supports the CDC's Section 317 immunization program, which distributes vaccines to state and local health departments across all fifty states, several large city programs, and U.S. Territories. Place of...
- This Indefinite Delivery Contract (IDC) was awarded to Sanofi Vaccines US Inc. (a division of Sanofi Pasteur Inc.) by the Centers for Disease Control and Prevention (CDC) on June 1, 2025, for the procurement of adult COVID-19 vaccines. The contract is structured as a multiple-award vehicle with no set-asides and carries a ceiling value of $12,658,200, with an ultimate completion date of May 31, 2026. As a civilian agency procurement, this IDC enables the CDC to issue delivery orders for adult...
- The Centers for Disease Control and Prevention, on behalf of its Office of Acquisition Services, awarded an indefinite-delivery, multiple-award contract to Moderna US, Inc. with a ceiling value of $29,183,000 and an award date of June 1, 2026. The contract runs through May 31, 2027. The solicitation, posted March 4, 2026 with proposals due March 17, 2026, sought FDA-approved COVID-19 vaccines for adults aged 19 and older to support the Section 317 immunization program, which distributes vaccines...
- Sanofi Vaccines US Inc. (Sanofi Pasteur Inc.) was awarded a multiple-award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) on July 1, 2025, with a ceiling value of $54.7 million and an ultimate completion date of June 30, 2026. The contract procures adult vaccines and covers a comprehensive range of immunization products to support federal immunization programs and public health initiatives. As a civilian contract with no set-aside designation, this vehicle...
- The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Sanofi Pasteur Inc. for the procurement of adult vaccines. The contracts have a potential value of $39.08 million to supply 13 standard adult vaccines over a one year period from July 1, 2021 through June 30, 2022. Vaccines will be delivered within 15 business days of order to support immunization programs in 50 state health departments and large cities, as provided under Section 317(j) of the Public...
- The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), awarded a multiple-award Indefinite Delivery Contract to Sanofi Pasteur Inc. to purchase 12 standard adult vaccines. The $42.2 million contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and does not have any set-aside designation. The solicitation required offerors to provide minimum and maximum order quantities ranging from 100 to 1,000,000 doses...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Moderna US, Inc. on June 1, 2026, with a ceiling of $285,044,250 and an ultimate completion date of May 31, 2027. This is an unrestricted procurement carrying no set-aside designation. Place of performance is centered in Chamblee, Georgia, with delivery to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky for refrigerated and frozen vaccines, or as...
- The Centers for Disease Control and Prevention awarded Sanofi Pasteur Inc. a multiple-award indefinite delivery contract with a potential value of $67,076,901.90 to procure adult flu vaccines for 2023-2024. No set-aside was used for this award. Under the terms of the contract, the awardee will deliver flu vaccines to the CDC through the period ending February 28, 2024. The solicitation sought to procure adult flu vaccines in support of the CDC's efforts to prevent the spread of influenza. As the...
- Sanofi Vaccines US Inc., a division of Sanofi Pasteur Inc., was awarded a Multiple Award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh on December 31, 2025, with a ceiling value of $18.07 million and ultimate completion date of February 28, 2027. This contract supports the procurement of adult influenza vaccines under the Vaccines for Children (VFC) program, which provides immunizations to eligible populations including Medicaid-beneficiaries,...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite delivery contract to Sanofi Pasteur Inc. to procure adult vaccines. With a potential value of $37.2 million, this vehicle provides for the delivery of various vaccine products and services over its one-year ordering period through June 2022. The contract supports the CDC's adult immunization programs by establishing competitive pricing for items like influenza, pneumococcal, tetanus-diphtheria-acellular pertussis,...